Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes
- Beth Israel Deaconess Medical Center, United States
- University of Copenhagen, Denmark
- University of Gothenburg, Sweden
- University of Oxford, United Kingdom
- University of Alberta, Canada
- Oxford University Hospitals, United Kingdom
- Imperial College London, United Kingdom
Additional files
-
All additional files
Any figure supplements, source code, source data, videos or supplementary files associated with this article are contained within this zip.
- https://cdn.elifesciences.org/articles/72919/elife-72919-supp-v1.zip
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes
eLife 10:e72919.
https://doi.org/10.7554/eLife.72919
